Bank of Montreal’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-576,425
Closed -$15.7M 4402
2016
Q4
$15.7M Sell
576,425
-34,560
-6% -$944K 0.02% 640
2016
Q3
$16.8M Buy
610,985
+58,464
+11% +$1.6M 0.02% 603
2016
Q2
$12.1M Buy
552,521
+13,901
+3% +$303K 0.01% 725
2016
Q1
$12M Buy
538,620
+99,381
+23% +$2.22M 0.01% 667
2015
Q4
$12.1M Buy
439,239
+67,343
+18% +$1.86M 0.01% 654
2015
Q3
$9.6M Buy
371,896
+144,283
+63% +$3.72M 0.01% 721
2015
Q2
$5.64M Buy
227,613
+4,708
+2% +$117K 0.01% 1026
2015
Q1
$5.62M Sell
222,905
-273,639
-55% -$6.9M 0.01% 1008
2014
Q4
$11.6M Sell
496,544
-46,643
-9% -$1.09M 0.01% 717
2014
Q3
$12.4M Buy
543,187
+1,457
+0.3% +$33.2K 0.01% 713
2014
Q2
$13.2M Buy
+541,730
New +$13.2M 0.01% 678

Other funds holding QGENF

Bank of Montreal's QGENF Position: Q1 2017 in Review

Bank of Montreal sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 576,425 shares — an estimated $15.7M sold.

Bank of Montreal first reported a position in QGENF in Q2 2014 and held it in 11 quarters. The position peaked at $16.8M in Q3 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Bank of Montreal reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Bank of Montreal sold 576,425 QIAGEN NV shares in Q1 2017, an estimated $15.7M.
  • Bank of Montreal first reported a position in QIAGEN NV in Q2 2014 and held it in 11 quarters.
  • Bank of Montreal's QIAGEN NV position peaked at $16.8M in Q3 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Bank of Montreal's 13F filing for Q1 2017, filed 11 Apr 2017.